At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
LABU Direxion Daily S&P Biotech Bull 3x Shares
Pre-Mkt 06-29 05:50:42 EDT
276.16
+18.36
+7.12%
盘前276.20
+0.04+0.01%
05:40 EDT
High279.32Low255.85Vol768.64K
Open255.85D1 Closing257.80Amplitude9.10%
Mkt Cap697.16MTradable Cap697.16MTotal Shares2.52M
T/O208.29MT/O Rate30.45%Tradable Shares2.52M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Chinese Biopharma Stocks Rally as Investors Favor Healthcare over AI
Dow Jones  ·  18 minutes ago
Chinese Biopharma Stocks Rally as Investors Favor Healthcare over AI
Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Monopar Therapeutics Inc (MNPR) and Bio-Techne (TECH)
TIPRANKS  ·  20 minutes ago
Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Monopar Therapeutics Inc (MNPR) and Bio-Techne (TECH)
Analysts’ Top Healthcare Picks: Revolution Medicines (RVMD), Apogee Therapeutics (APGE)
TIPRANKS  ·  16:50
Analysts’ Top Healthcare Picks: Revolution Medicines (RVMD), Apogee Therapeutics (APGE)
BrainAurora Wins Xiongan AI Healthcare Competition and Unveils Key Brain Science Breakthroughs
TIPRANKS  ·  16:39
BrainAurora Wins Xiongan AI Healthcare Competition and Unveils Key Brain Science Breakthroughs
Health Care Roundup: Market Talk
Dow Jones  ·  16:20
Health Care Roundup: Market Talk
Index Exit And C-Suite Shift Could Be A Game Changer For HCA Healthcare (HCA)
Simply Wall St.  ·  15:11
Index Exit And C-Suite Shift Could Be A Game Changer For HCA Healthcare (HCA)
ASCLETIS-B Shares Surge Over 7% on FDA IND Approval for ASC35 Phase I Study and GIC's Consistent Share Purchases
Stock News  ·  14:22
ASCLETIS-B Shares Surge Over 7% on FDA IND Approval for ASC35 Phase I Study and GIC's Consistent Share Purchases
Why Viridian Therapeutics (VRDN) Is Up 7.6% After FDA Clears First All‑Stage Thyroid Eye Drug
Simply Wall St.  ·  11:21
Why Viridian Therapeutics (VRDN) Is Up 7.6% After FDA Clears First All‑Stage Thyroid Eye Drug
Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (ACAD) and Insmed (INSM)
TIPRANKS  ·  08:40
Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (ACAD) and Insmed (INSM)
Algorae Joins Sovereign AI Infrastructure as Healthcare Launch Partner
TIPRANKS  ·  07:43
Algorae Joins Sovereign AI Infrastructure as Healthcare Launch Partner
Is DexCom (DXCM) A Bargain On FDA Cleared Stelo Expansion?
Simply Wall St.  ·  07:12
Is DexCom (DXCM) A Bargain On FDA Cleared Stelo Expansion?
Healius Signs National Agreement Framework With Ramsay Health Care
MT Newswires Live  ·  05:45
Healius Signs National Agreement Framework With Ramsay Health Care
Vital Healthcare Manager’s Stake in Trust Falls as Control Rights Narrow
TIPRANKS  ·  04:47
Vital Healthcare Manager’s Stake in Trust Falls as Control Rights Narrow
BridgeBio Announces Publication in the New England Journal of Medicine of Phase 3 PROPEL 3 Trial of Oral Infigratinib in Children Living with Achondroplasia
GlobeNewswire  ·  04:00
BridgeBio Announces Publication in the New England Journal of Medicine of Phase 3 PROPEL 3 Trial of Oral Infigratinib in Children Living with Achondroplasia
Fluor (FLR) Could Be 6% Above Fair Value After New Healthcare Project Wins
Simply Wall St.  ·  06-28 10:13
Fluor (FLR) Could Be 6% Above Fair Value After New Healthcare Project Wins
Australian Penny Stocks With Strong Balance Sheets Worth A Closer Look
Simply Wall St.  ·  06-28 09:14
Australian Penny Stocks With Strong Balance Sheets Worth A Closer Look
Capricor Therapeutics (CAPR) Is Down 6.8% After Positive Five-Year HOPE-2 DMD Data And FDA Update
Simply Wall St.  ·  06-28 07:13
Capricor Therapeutics (CAPR) Is Down 6.8% After Positive Five-Year HOPE-2 DMD Data And FDA Update
Analysts Offer Insights on Healthcare Companies: ADC Therapeutics (ADCT) and Lantheus (LNTH)
TIPRANKS  ·  06-27 21:30
Analysts Offer Insights on Healthcare Companies: ADC Therapeutics (ADCT) and Lantheus (LNTH)
Inhibrx Biosciences (INBX) Wins FDA Filing Acceptance, Is More Upside Already Priced In?
Simply Wall St.  ·  06-27 18:16
Inhibrx Biosciences (INBX) Wins FDA Filing Acceptance, Is More Upside Already Priced In?
Health Care Roundup: Market Talk
Dow Jones  ·  06-27 16:20
Health Care Roundup: Market Talk

Introduction

Company Name.
Direxion Daily S&P Biotech Bull 3x Shares
Affiliated Markets:
ARCA
Listing Date:
--
Main Business:
The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Issue price:
--